Avista Therapeutics
Jane Opgaard has a varied work experience starting from 2008. Jane worked at Mediterranean Wellness as a Business Manager, where they managed financial operations and assisted in proposal writing and grant submissions. From 2010 to 2019, Jane worked at SpiralGen, Inc. as EVP Operations, overseeing corporate and grant financial reporting, operations control, tax, budget management, and grant administration. Jane then worked as an Entrepreneur in Residence at Carnegie Mellon University from 2018 to 2019. From 2019 to 2022, they held multiple roles at BlueSphere Bio, including Operations Manager, Director of Operations, and Senior Director of Procurement and Operations. Currently, they are Vice President of Operations at Avista Therapeutics, starting from May 2022.
Jane Opgaard holds a Master of Business Administration (MBA) degree from the University of Washington - Michael G. Foster School of Business. Jane also obtained a Bachelor of Arts (BA) degree in International Studies with a concentration in Japan from the University of Washington, Henry M. Jackson School of International Studies. Additionally, Jane has earned a Lean Six Sigma Green Belt certification from Purdue University Online in May 2022.
This person is not in any teams
This person is not in any offices
Avista Therapeutics
Avista's mission is to develop innovative gene therapies for retinal diseases, including rare, inherited conditions that have a profound impact on patients' quality of life. We leverage our computationally guided scAAVengr platform to generate and validate a toolkit of proprietary AAV vectors that overcome the most significant obstacles to effective gene therapies, including cell-type specific delivery, reduced dosages, and efficient expression, using a minimally invasive intravitreal approach. Our quantitative, in vivo-based approach and clinical ophthalmology expertise allow us to rapidly translate new gene therapies to the clinic. Avista is a UPMC Enterprises portfolio company founded based on the research of Drs. Leah Byrne, Jose Sahel, and Paul Sieving.
Employees
1-10